Metformin, a medication used to treat Diablete Mellitus type 2, inproves the response of new immunotherapies in patients with diseminated melanoma.

This was the results of of the retropsective analysis of 55 metastatic melanoma patients. the progression free of disease was extended more thna 3 times and the survival almost the double in patients who were taken metformin are recieved the immune check-point inhibitors. . Propective clinical triasl are now planned to get mor data related to this finding.